CPC-001-07A Phase II, Single-Blind, Placebo-Controlled, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Donepezil with Solifenacin in Patients with Alzheimers Disease Type Dementia